TNG456 — Initial data
2H 2026
Release initial TNG456 data in glioblastoma and other cancers in 2H 2026Source filing
TNGX biotech catalysts & pipeline
TANGO THERAPEUTICS INC · Data as of 2026-09-08
Upcoming catalysts
vopimetostat — Initial data
2H 2026
Disclose vopimetostat lung cancer monotherapy data in 2H 2026Source filing
vopimetostat — Conference presentation
Oct 23–Oct 27
Phase 1/2 data from combination study of vopimetostat + RAS(ON) inhibitors in pancreatic cancer to be presented at 2026 ESMO CongressSource filing